🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Treatment of higher-risk (intermediate, high and very high) Myelodysplastic...
Status
Completed
Location
AOU Careggi- University of Florence
Start Date
2021-03-24
Trial ID
NCT04806906
Treatments Being Tested
Myelodysplastic Syndrome (MDS) is a group of blood disorders where the bone...
Status
Completed
Location
Calvary Mater Newcastle
Start Date
2018-05-18
Trial ID
NCT03493646
Treatments Being Tested
The purpose of this study is to determine whether a tablet form of azacitid...
Status
Completed
Location
University of Florida
Start Date
2007-09-11
Trial ID
NCT00528983
Treatments Being Tested
Evaluate the safety and efficacy of oral azacitidne (CC-486) twice daily (B...
Status
Completed
Location
Local Institution - 113
Start Date
2015-07-06
Trial ID
NCT02281084
Treatments Being Tested
This study focuses on finding a safe and tolerable dose for a three-drug re...
Status
Terminated
Location
University of Chicago Medical Center
Start Date
2021-09-01
Trial ID
NCT04722601
Treatments Being Tested
This is a Phase 2, open-label, multicenter study to assess the efficacy and...
Status
Completed
Location
UCSF Helen Diller Medical Center at Parnassus Heights
Start Date
2015-01-07
Trial ID
NCT02250326
Treatments Being Tested
This phase II/III trial compares the side effects and activity of oral azac...
Status
Active Not Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2021-05-20
Trial ID
NCT04799275
This study is a multicentric, open-label, randomized phase 3 trial. The stu...
Status
Completed
Location
Local Institution - 41822
Start Date
2018-11-06
Trial ID
NCT03703375
Treatments Being Tested
The purpose of this study is to determine the safety and tolerability of ad...
Status
Completed
Location
Medical University of South Carolina
Start Date
2019-04-04
Trial ID
NCT03450343
Treatments Being Tested
This is an open label, dose escalation Phase I single institution pilot stu...
Status
Recruiting
Location
CU Anschutz Medical Campus
Start Date
2022-12-19
Trial ID
NCT05287568
Treatments Being Tested